貧血治療薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00005400
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Anemia Drugs Market Insights and Growth by 2031

Buy Now

市場紹介
貧血は、ヘモグロビンが正常より低い病状です。ヘモグロビンが低下すると、血液が酸素を運ぶ能力が低下します。貧血は一般に、失血、赤血球の分解の増加、および赤血球の産生の減少によって引き起こされます。貧血は男性よりも女性に多く見られます。貧血の主な症状には、息切れ、めまい、疲労感、動悸などがあります。

市場のダイナミクス
貧血治療薬市場は、高齢者人口の増加、人々の栄養不足、栄養不足などの要因により、今後数年間成長すると予想されています。がん、糖尿病、腎臓病などの慢性疾患の有病率。しかし、貧血治療薬の投与に伴う副作用が市場の成長を妨げると予想されます。その一方で、先進国と発展途上国で貧血に対する意識が高まっており、貧血治療薬に関連する研究開発は市場成長の新たな機会を提供する可能性があります。

市場範囲
「2031年までの世界の貧血薬市場分析」は、世界市場の傾向分析に特に焦点を当てた専門的で詳細な調査です。このレポートは、タイプ、投与経路、製品タイプ、エンドユーザー、地域ごとに詳細な市場分割を行い、貧血薬市場の概要を提供することを目的としています。世界の貧血薬市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、貧血薬市場の主要プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション
世界的な貧血医薬品市場は、種類、投与経路、製品の種類、エンドユーザーに基づいて分割されています。種類に基づいて、市場は鉄欠乏性貧血、鎌状赤血球貧血、再生不良性貧血、溶血性貧血、悪性貧血などに分類されます。投与経路に基づいて、市場は経口剤と注射剤に分類されます。製品タイプに基づいて、貧血薬市場は生物製剤と非生物製剤に分類されます。エンドユーザーに基づいて、市場は病院、自己管理、その他に分類されます。

Anemia Drugs Market: Strategic Insights

Anemia Drugs Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Amgen Inc
  • GlaxoSmithKline plc
  • bluebird bio Inc
  • Biocon
  • GlycoMimetics
  • Regen biopharma Inc
  • Bayer AG
  • Acceleron Pharma Inc
  • Eli Lilly and Company

Regional Overview

Regional And Country Scope
  • 北米
  • ヨーロッパ
  • アジア太平洋
  • 南米および中米
  • 中東およびアフリカ

Market Segmentation

Segment 1種類
  • 鉄欠乏性貧血
  • 鎌状赤血球貧血
  • 再生不良性貧血
  • 溶血性貧血
  • 悪性貧血
  • その他
Segment2投与経路
  • 経口
  • 注射
Segment3製品タイプ
  • 生物製剤
  • 非生物製剤
Segment4エンドユーザー
  • 病院
  • 自家投与
  • その他

このレポートは、以下を含む業界の詳細な概要を提供します。定性的情報と定量的情報の両方。さまざまなセグメントに基づいた世界の貧血薬市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南および南。中米。各地域別の貧血薬市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界18か国の分析と予測、およびこの地域で広まっている現在の傾向と機会をカバーしています。

レポートは、需要と供給の両方の側面から貧血薬市場に影響を与える要因を分析し、貧血薬市場に影響を与える市場力学をさらに評価します。予測期間中の市場、つまり推進要因、制約、機会、将来の傾向。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南および南。中米地域の貧血薬市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。

市場参加者
レポートでは、有機的および無機的成長戦略としての貧血薬市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、提携および提携でした。コラボレーション。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。貧血薬市場のプレーヤーは、世界市場での貧血薬の需要の高まりに伴い、将来的に有利な成長機会が期待されています。以下は、貧血薬市場に従事するいくつかの企業のリストです。

レポートには、SWOT分析と市場戦略とともに、主要な貧血薬市場企業のプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、会社概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を提供しています。
  • Amgen Inc.< /li>
  • GlaxoSmithKline plc.
  • bluebird bio, Inc.
  • Biocon.
  • GlycoMimetics
  • Regen biopharma Inc.< /li>
  • バイエル AG
  • アクセレロン ファーマ株式会社
  • イーライ リリー アンド カンパニー
  • 武田薬品工業株式会社
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。

Anemia Drugs Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 種類
  • 鉄欠乏性貧血
  • 鎌状赤血球貧血
  • 再生不良性貧血
  • 溶血性貧血
  • 悪性貧血
  • その他
By 投与経路
  • 経口
  • 注射
By 製品タイプ
  • 生物製剤
  • 非生物製剤
By エンドユーザー
  • 病院
  • 自家投与
  • その他
Regions and Countries Covered 北米
  • 米国
  • カナダ
  • メキシコ
ヨーロッパ
  • 英国
  • ドイツ
  • フランス
  • ロシア
  • イタリア
  • その他のヨーロッパ
アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他のアジア太平洋
南米および中米
  • ブラジル
  • アルゼンチン
  • その他の中南米
中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • UAE
  • その他の中東およびアフリカ
Market leaders and key company profiles
  • Amgen Inc
  • GlaxoSmithKline plc
  • bluebird bio Inc
  • Biocon
  • GlycoMimetics
  • Regen biopharma Inc
  • Bayer AG
  • Acceleron Pharma Inc
  • Eli Lilly and Company
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Amgen Inc.
    2. GlaxoSmithKline plc.
    3. bluebird bio, Inc.
    4. Biocon.
    5. GlycoMimetics
    6. Regen biopharma Inc.
    7. Bayer AG
    8. Acceleron Pharma, Inc.
    9. Eli Lilly and Company
    10. Takeda Pharmaceutical Company Limited.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..